IDiyas

For the Inventor, By the Inventor

Rancho Santa Margarita, CA, United States of America

Arlene M Buller

USPTO Granted Patents = 15 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal15 out of 479 
 
Quest Diagnostics Investments, Inc.
 patents

Years Active: 2010-2022

Loading Chart...
15 patents (USPTO):Explore Patents
1. 11447826 - Cystic fibrosis transmembrane conductance regulator gene mutations (2022-09-20),
2. 10793910 - Cystic fibrosis gene mutations (2020-10-06),
3. 10501799 - Cystic fibrosis transmembrane conductance regulator gene mutations (2019-12-10),
4. 9909183 - Cystic fibrosis transmembrane conductance regulator gene mutations (2018-03-06),
5. 9840740 - Cystic fibrosis gene mutations (2017-12-12),
6. 9410203 - Cystic fibrosis transmembrane conductance regulator gene mutations (2016-08-09),
7. 9228237 - Cystic fibrosis gene mutations (2016-01-05),
8. 8753817 - Cystic fibrosis transmembrane conductance regulator gene mutations (2014-06-17),
9. 8460871 - Cystic fibrosis gene mutations (2013-06-11),
10. 8338578 - Cystic fibrosis gene mutations (2012-12-25),
11. 8124345 - Cystic fibrosis transmembrane conductance regulator gene mutations (2012-02-28),
12. 8076078 - Cystic fibrosis gene mutations (2011-12-13),
13. 7820388 - Cystic fibrosis transmembrane conductance regulator gene mutations (2010-10-26),
14. 7803548 - Methods for diagnosing cystic fibrosis (2010-09-28),
15. 7794937 - Cystic fibrosis transmembrane conductance regulator gene mutations (2010-09-14),

Title: Arlene M Buller: Innovator in Cystic Fibrosis Research

Introduction

Arlene M Buller is a prominent inventor based in Rancho Santa Margarita, CA (US). She has made significant contributions to the field of genetics, particularly in relation to cystic fibrosis. With a total of 15 patents, her work has advanced the understanding and detection of genetic mutations associated with this condition.

Latest Patents

Among her latest patents, Arlene has developed innovative methods related to cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations. These inventions provide novel mutations of the CFTR gene that are linked to cystic fibrosis and related conditions. Additionally, her patents include probes for detecting mutant sequences and methods for identifying individuals with genotypes containing one or more mutations in the CFTR gene.

Career Highlights

Arlene M Buller is currently associated with Quest Diagnostics Investments, Inc., where she continues her research and development efforts. Her work has been instrumental in enhancing the diagnostic capabilities for cystic fibrosis, thereby improving patient outcomes.

Collaborations

Throughout her career, Arlene has collaborated with notable colleagues, including Matthew J McGinniss and Franklin Quan. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of genetic research.

Conclusion

Arlene M Buller stands out as a key figure in the field of cystic fibrosis research, with her patents paving the way for improved diagnostic methods. Her contributions are vital to the ongoing efforts to understand and treat this genetic condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…